Device Trial Radar · NCT03883217
Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease
Last checked: Nov 20, 2026Latest source record: Mar 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Jun 29, 2021
Primary completion
Jan 11, 2022
Study completion Jan 11, 2022
Sponsor
- Lead sponsor
- Virginia Commonwealth UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Michael J. Fox Foundation for Parkinson's Research
- First posted
- Mar 20, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 95 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research study is to test the safety, tolerability, and the effect of vibration (delivered by an experimental device called PDVibe2) on freezing of gait (FOG) in persons with Parkinson's disease (PD). The PDVibe2 was developed by Resonate Forward, LLC (RF). This PDVibe2 was designed to administer vibration therapy to the wearer to improve gait and balance in persons with PD while wearing the device.
Conditions
- Parkinson Disease
Interventions
Vibration SessionDevice
The PDVibe2 is owned by Resonate Forward, LLC and will be loaned to Virginia Commonwealth University (VCU) for this project. The device is non-invasive, lightweight, untethered, contains a rechargeable battery, and is worn on both feet and ankles. PDVibe2 delivers vibration when activated by an easy to access switch on the device or by remote. The internal circuitry has been miniaturized, is encased in a small box, and is attached to the ankle using a soft flexible band.
No vibration sessionDevice
The PDVibe2 is owned by Resonate Forward, LLC and will be loaned to Virginia Commonwealth University (VCU) for this project. The device is non-invasive, lightweight, untethered, contains a rechargeable battery, and is worn on both feet and ankles. During this session, PDVibe2 delivers no vibration but is still worn. The internal circuitry has been miniaturized, is encased in a small box, and is attached to the ankle using a soft flexible band.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Functional Ambulation Profile (FAP) ScoreTime frame: Throughout study completion, from 9 to 34 days.
- Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS)Time frame: Throughout study completion, from 9 to 34 days.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Virginia Commonwealth University
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.